Diagnostic Value of Autoantibodies against Ezrin in Esophageal Squamous Cell Carcinoma

Table 4

Relationship between positive rate of the autoantibody and clinicopathologic features in ESCC patients.

Group		Positive (%)	value
Patient age
≤55	57	11 (19.3%)	0.077
>55	92	30 (32.6%)
Patient gender
Female	42	12 (28.6%)	0.857
Male	107	29 (27.1%)
Tumor invasion Depth
T1 + T2	32	10 (31.3%)	0.599
T3 + T4	113	30 (26.5%)
Lymph node metastasis
Positive	72	18 (25.0%)	0.506
Negative	77	23 (29.9%)
Histological grade
High	40	8 (20.0%)	0.274
Medium	93	30 (32.3%)
Low	15	3 (20.0%)
TNM stage
I	14	4 (28.6%)	0.234
II	57	15 (26.3%)
III	44	20 (45.5%)
IV	3	1 (33.3%)
Tumor size
<5 cm	89	27 (30.3%)	0.348
≥5 cm	60	14 (23.3%)
Tumor Site
Upper thorax	17	3 (17.6%)	0.364
Middle thorax	111	30 (27.0%)
Lower thorax	21	8 (38.1%)
Early-stage versus advanced-stage
Early-stage	18	5 (27.8%)	0.979
Advanced-stage	131	36 (27.5%)

Statistical significance was determined by means of Chi-squared test.